HOME Top Market Reports Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021

Mice Model Market by Type (Inbred, Knockout, Hybrid), Technology (CRISPR, Microinjection), Application (Oncology, Diabetes), Service (Breeding, Quarantine, Genetic testing) & Care Products (Bedding, Feed) - Analysis & Global Forecast to 2021

By: marketsandmarkets.com
Publishing Date: February 2017
Report Code: BT 2192

 

  Speak to Analyst Enquiry Before Buying Webinar
purchase report
download pdf  request for customisation


Mice models are indispensable in research activities dealing with human disease processes due to striking similarities between the anatomy, physiology, and genetics of humans and mice. These advantages promote scientific discovery, understanding of the functions of individual genes, mechanisms of different diseases, and the effectiveness and toxicities of various drug molecules. The mice model market is projected to reach USD 1.59 Billion by 2021 from USD 1.11 Billion in 2016, at a CAGR of 7.5% in the next five years (2016 to 2021). The growth of the market can be attributed to ongoing innovations in mice models, continuous support in the form of investments and grants, and growing demand for humanized mice models. On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the mice model market to some extent. In addition, increased benefits from cryopreservation, and regulations & laws for the ethical use of animals are some factors expected to restrain the growth of the market.

Objectives of the Study

  • To define, describe, and measure the global mice model market on the basis of type, technology, application, service, mice care product, and region
  • To provide detailed information regarding the major factors, such as drivers, restraints, growth opportunities, and challenges influencing the growth of the market
  • To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the global mice model market
  • To analyze the opportunities in the global mice model market for key stakeholders and provide details of the competitive landscape for major market leaders
  • To forecast the size of the market segments with respect to four main regions, namely, North America, Europe, Asia-Pacific, and Rest of the World
  • To strategically analyze the market structure and profile the key players of the global mice model market and comprehensively analyze their core competencies
  • To track and analyze competitive developments such as partnerships, agreements, alliances, joint ventures, collaborations, product launches, expansions, acquisitions, grants/funds, and licensing agreements, among others in the mice model market.

Research Methodology

Top-down and bottom-up approaches were used to validate the size of the global mice model market and estimate the size of various other dependent submarkets in the overall mice model market Various secondary sources such as directories, industry journals, databases such as Hoover’s, Bloomberg Business, Factiva, and Avention, and annual reports of the companies have been used to identify and collect information useful for the study of this market. Primary sources such as experts from both supply and demand sides have been interviewed to obtain and validate information as well as to assess dynamics of this market. The breakdown of profiles of primaries is shown in the figure below:

Mice Model Market

To know about the assumptions considered for the study, download the pdf brochure

Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratory Corporation of America Holdings (U.S.), JANVIER LABS (France), Harbour BioMed (China), TRANS GENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (U.S.) are some of the key players in the mice model market across the globe.

Target Audience:

  • Mice models and services companies
  • Mice model and services distributors
  • Animal care products manufacturers and suppliers
  • Out–licensing life sciences companies (Pharmaceutical/Biopharmaceutical/Biotechnology)
  • In–licensing life sciences companies (Pharmaceutical/Biopharmaceutical/Biotechnology)
  • Clinical research organizations (CROs)
  • Academic institutes
  • Government and private research institutes
  • Medical research centers
  • Public and private animal health agencies
  • Animal care associations
  • Venture Capitalists

Scope of the Report:

This research report categorizes the global mice model market into the following segments:

Mice Model Market, by Type

  • Inbred Mice
  • Genetically Engineered Mice
  • Conditioned/Surgically Modified Mice
  • Hybrid/Congenic Mice
  • Outbred Mice
  • Spontaneous Mutant Mice

Mice Model Market, by Technology

  • CRISPR
  • Microinjection
  • Embryonic Stem Cell Injection
  • Nuclear Transfer
  • Other Technologies (Genetically modified sperm-mediated Gene Transfer, Virus/Vector-mediated Gene Transfer, Liposome-mediated DNA & Electroporation of DNA, Biolistics, and TALENs & ZFN)

Mice Model Market, by Application

  • Oncology Studies
  • Immunology and Inflammation Studies
  • Diabetes Studies
  • Cardiovascular Studies
  • Central Nervous System Studies
  • Other Disease Studies (Rare Diseases, Renal Disorders, Haematopoiesis, Toxicology, among others)

Mice Model Market, by Service

  • Breeding Services
  • Cryopreservation
  • Quarantine
  • Rederivation
  • Genetic Testing
  • Model in licensing
  • Other Services (Surgical, Line Rescue, In Vivo Pharmacology Services)

Mice Care Products Market, by Type

  • Bedding
  • Cages
  • Feed
  • Other Care Products (Gnotobiotic Equipment, Water Systems, Accessories)
  • *Note: Accessories include washing systems, logistics, water purification systems, and sound absorption panels.

Mice Model Market, by Region

  •  North America
    • U.S.
    • Canada
  •  Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe (RoE)
  •  Asia-Pacific
    • China
    • Japan
    • India
    • Rest of APAC
  • Rest of the World (RoW)

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization option is available for the report:

Portfolio Assessment

Product Matrix, which gives a detailed comparison of the product portfolios of the top three companies in the market.

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Limitations
    1.6 Stakeholders

2 Research Methodology (Page No. - 26)
    2.1 Research Methodology Steps
    2.2 Secondary and Primary Research Methodology
           2.2.1 Secondary Research
                     2.2.1.1 Key Data From Secondary Sources
           2.2.2 Primary Research
                     2.2.2.1 Key Industry Insights
                     2.2.2.2 Key Data From Primary Sources
                     2.2.2.3 Key Insights From Primary Sources
    2.3 Market Size Estimation Methodology
    2.4 Market Forecast Design
    2.5 Market Data Validation and Triangulation
    2.6 Assumptions

3 Executive Summary (Page No. - 37)
    3.1 Introduction
    3.2 Conclusion

4 Premium Insights (Page No. - 44)
    4.1 Mice Model Market: Overview
    4.2 Geographic Analysis: Global Mice Care Products Market, By Type
    4.3 Global Mice Model Market, By Technology, 2016 vs 2021
    4.4 Regional Snapshot of the Global Market For Mice Model

5 Market Overview (Page No. - 47)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
                     5.2.1.1 Ongoing Innovations in Mice Models
                                         5.2.1.1.1 Mice Models for Immune Diseases
                                         5.2.1.1.2 Mice Models for Cancer
                                         5.2.1.1.3 Mice Models for Rare Diseases
                     5.2.1.2 Growing Consumption of Personalized Medicine Driving the Demand for Humanized Mice Models
                     5.2.1.3 Continuous Support in the Form of Grants and Investments
                     5.2.1.4 Growing Number of Pharmaceutical R&D Activities
                     5.2.1.5 Increasing Focus of Associations on the Development of Embryonic Stem Cells as Well as Knockout and Mutant Mice
                                         5.2.1.5.1 International Mouse Phenotyping Consortium (Impc)
                                         5.2.1.5.2 International Knockout Mouse Consortium (Ikmc)
           5.2.2 Restraints
                     5.2.2.1 Growing Use of Rat Models
                     5.2.2.2 Increased Benefits From Cryopreservation
                     5.2.2.3 Regulations and Laws for Ethical Use of Animals in Research
                                         5.2.2.3.1 the Animal Welfare Act
                                         5.2.2.3.2 Public Health Service Policy on Humane Care and Use of Laboratory Animals
           5.2.3 Opportunities
                     5.2.3.1 Emergence of Crispr as A Powerful Tool in the Field of Biomedical Research
                     5.2.3.2 Rising Demand for Humanized Mice Models
                     5.2.3.3 Increase in Monoclonal Antibody Production
           5.2.4 Challenges
                     5.2.4.1 Development of Alternative Methods to Animal Testing
                     5.2.4.2 Advancements in Zebrafish Model Development
                     5.2.4.3 Growing Need for Improved Mice Models

6 Regulatory Assessment (Page No. - 57)
    6.1 Introduction
    6.2 North America
    6.3 Europe
    6.4 China
    6.5 Japan
    6.6 India
    6.7 Australia
    6.8 Brazil

7 Clinical Studies Assessment (Page No. - 62)
    7.1 Introduction
    7.2 Clinical Studies
    7.3 Clinical Studies Assessment

8 Mice Model Market, By Type (Page No. - 65)
    8.1 Introduction
    8.2 Inbred Mice
    8.3 Outbred Mice
    8.4 Genetically Engineered Mice
    8.5 Hybrid/Congenic Mice
    8.6 Conditioned/Surgically Modified Mice
    8.7 Spontaneous Mutant Mice

9 Mice Model Market, By Service (Page No. - 75)
    9.1 Introduction
    9.2 Breeding
    9.3 Cryopreservation
    9.4 Quarantine
    9.5 Rederivation
    9.6 Model In-Licensing
    9.7 Genetic Testing
    9.8 Other Services

10 Mice Model Market, By Technology (Page No. - 85)
     10.1 Introduction
     10.2 Crispr/Cas9
     10.3 Microinjection
     10.4 Embryonic Stem Cell Injection
     10.5 Nuclear Transfer
     10.6 Other Technologies
               10.6.1 Genetically Modified Sperm-Mediated Gene Transfer
               10.6.2 Virus/Vector-Mediated Gene Transfer
               10.6.3 Liposome-Mediated DNA and Electroporation of DNA
               10.6.4 Biolistics
               10.6.5 Talens and Zfns

11 Mice Model Market, By Application (Page No. - 94)
     11.1 Introduction
     11.2 Oncology Studies
               11.2.1 Continuous Grants/Funds Supporting Cancer Research Studies
               11.2.2 Agreements & Collaborations Strengthening Cancer Research
               11.2.3 Introduction of New Mice Models for Specific Cancers
               11.2.4 Expansions Supporting Cancer Research
     11.3 Immunology and Inflammation Studies
     11.4 Diabetes Studies
     11.5 Cardiovascular Studies
     11.6 Central Nervous System (Cns) Studies
               11.6.1 Grants/Funds Supporting Neurological Research
     11.7 Other Disease Studies

12 Mice Care Products Market, By Type (Page No. - 108)
     12.1 Introduction
     12.2 Cages
     12.3 Feed
     12.4 Bedding
     12.5 Other Care Products

13 Mice Model Market, By Region (Page No. - 115)
     13.1 Introduction
     13.2 North America
               13.2.1 U.S.
                           13.2.1.1 Increased Focus on Biomedical Research in the U.S.
                           13.2.1.2 Rise in Monoclonal Antibody Production to Augment the Use of Mice Models
                           13.2.1.3 Increased Activities By Animal Care Organizations to Create Awareness on Ethical Usage of Animals in Research
                           13.2.1.4 Development of Biosimilars Boosting the Demand for Preclinical Services
                           13.2.1.5 Nexus Between Cros and Pharmaceutical Companies: Outsourcing, Partnerships to Aid Market Growth
               13.2.2 Canada
                           13.2.2.1 Growth in Stem Cell Research Activities
                           13.2.2.2 Government Support for Development of Protein Drugs
     13.3 Europe
               13.3.1 Germany
                           13.3.1.1 Launch of Pro-Test Deutschland
                           13.3.1.2 Growing Biotechnology Industry
               13.3.2 U.K.
                           13.3.2.1 Demand for Statistically Robust Results for Animal Studies
                           13.3.2.2 Increase in Cell Therapy Preclinical Research
               13.3.3 France
                           13.3.3.1 Funding for Rare Disease Projects in France
               13.3.4 Rest of Europe (RoE)
                           13.3.4.1 Rising Usage of Custom Mice Models in Cancer Research
                           13.3.4.2 Events Conducted By Animal Care Associations to Promote the Ethical Use of Mice
                           13.3.4.3 Rising Focus on Rare Disease-Related Research
                           13.3.4.4 Improving Biomedical Industry in Russia
                           13.3.4.5 Growth in the Biotech and Pharma Sector of Italy
                           13.3.4.6 Sweden & Denmark: Growing Investments in Research
     13.4 Asia-Pacific
               13.4.1 China
                           13.4.1.1 Rising Focus on Precision Medicine and Personalized Medicine
                           13.4.1.2 International Alliances for R&D Activities
                           13.4.1.3 Growing Focus on Pharmaceutical and Mice Model Suppliers
                           13.4.1.4 Public and Private Investments in China’s Life Sciences Sector
                           13.4.1.5 Initiatives to Reduce Long Approval Times
                           13.4.1.6 Intellectual Property (Ip) Breaches, A Challenge for Market Growth
               13.4.2 Japan
                           13.4.2.1 Growth in Biomedical and Medical Research
                           13.4.2.2 Rising Focus on Life Science Research Activities Like Regenerative Medicine
               13.4.3 India
                           13.4.3.1 Development of Bioclusters to Boost India’s Biotechnology Industry
                           13.4.3.2 Rising R&D Expenditure, an Indicator of Growth in Research Intensity
                           13.4.3.3 Shifting of Outsourcing Preclinical Activities From India Towards European Nations
                           13.4.3.4 Limited Infrastructural Facilities in India
                           13.4.3.5 Weak Intellectual Property Protection
               13.4.4 Rest of Asia-Pacific (RoAPAC)
                           13.4.4.1 Influx of International Players
                           13.4.4.2 Ongoing Biomedical Research Activities in Australia
                           13.4.4.3 Rising Translational and Biomedical Research in SingAPOre
                           13.4.4.4 Increase in Animal Research in Malaysia
                           13.4.4.5 Rising Pharmaceutical and Biotechnology R&D in Korea
               13.4.5 Rest of the World (RoW)
                           13.4.5.1 Rising R&D in Brazilian Pharmaceutical, Biotechnology, and Research Industries to Bolster Market Growth
                           13.4.5.2 Growing Pharmaceutical and Biotechnology Industries in Saudi Arabia and the UAE

14 Mice Model Market: Competitive Landscape (Page No. - 178)
     14.1 Overview
     14.2 Market Share Analysis (2015)
               14.2.1 Charles River Laboratories International, Inc.
               14.2.2 The Jackson Laboratory
               14.2.3 Taconic Biosciences, Inc.
               14.2.4 ENVIGO (Harlan Laboratories, Inc.)
     14.3 Competitive Situation and Trends
               14.3.1 Alliances, Collaborations, Agreements, Partnerships, and Joint Ventures
               14.3.2 Grants & Funds
               14.3.3 Expansions
               14.3.4 Product Launches
               14.3.5 Acquisitions
               14.3.6 Licensing
               14.3.7 Others

15 Company Profiles (Page No. - 196)
(Overview, Products and Services, Financials, Strategy & Development)*
     15.1 Introduction
     15.2 Charles River Laboratories International, Inc.
     15.3 The Jackson Laboratory
     15.4 Taconic Biosciences, Inc.
     15.5 ENVIGO
     15.6 Laboratory Corporation of America Holdings
     15.7 Janvier Labs
     15.8 Harbour Antibodies Bv (A Subsidiary of Harbour Biomed)
     15.9 Trans Genic, Inc.
     15.10 Genoway
     15.11 Horizon Discovery Group PLC  (Sage Labs, Inc.)
     15.12 Ingenious Targeting Laboratory

*Details on Overview, Products and Services, Financials, Strategy & Development Might Not Be Captured in Case of Unlisted Companies

16 Appendix (Page No. - 244)
     16.1 Discussion Guide
     16.2 Other Developments (2013–2016)
               16.2.1 Charles River Laboratories International, Inc.
               16.2.2 The Jackson Laboratory (JAX)
               16.2.3 Taconic Biosciences Inc.
               16.2.4 ENVIGO
               16.2.5 Laboratory Corporation of America Holdings (Covance, Inc.)
               16.2.6 Trans Genic, Inc.
               16.2.7 Genoway
               16.2.8 Horizon Discovery Group PLC  (Sage Labs, Inc.)
     16.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     16.4 Introducing RT: Real-Time Market Intelligence
     16.5 Available Customizations
     16.6 Related Reports
     16.7 Author Details


List of Tables (116 Tables)

Table 1 Sampling Frame: Primary Research
Table 2 Indicative List of Clinical Studies Conducted Using Mice Models
Table 3 Global Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 4 Inbred Market For Mice Model: Size, By Country, 2014–2021 (USD Million)
Table 5 Outbred Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 6 Genetically Engineered Mice (Knockout/Knockin) Model Market Size, By Country, 2014–2021 (USD Million)
Table 7 Hybrid/Congenic Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 8 Conditioned/Surgically Modified Market Size, By Country, 2014–2021 (USD Million)
Table 9 Spontaneous Mutant Market Size, By Country, 2014–2021 (USD Million)
Table 10 Global Mice Model Market, Size, By Service, 2014–2021 (USD Million)
Table 11 Breeding Services Market Size, By Country, 2014–2021 (USD Million)
Table 12 Cryopreservation Services Market Size, By Country, 2014–2021 (USD Million)
Table 13 Quarantine Services Market Size, By Country, 2014–2021 (USD Million)
Table 14 Rederivation Services Market Size, By Country, 2014–2021 (USD Million)
Table 15 Model in Licensing Services Market Size, By Country, 2014–2021 (USD Million)
Table 16 Genetic Testing Services Market Size, By Country, 2014–2021 (USD Thousand)
Table 17 Other Services Market Size, By Country, 2014–2021 (USD Thousand)
Table 18 Global Mice Model Market, By Technology, 2014–2021 (USD Million)
Table 19 Market Size for Crispr, By Country, 2014–2021 (USD Million)
Table 20 Market Size for Microinjection, By Country, 2014–2021 (USD Million)
Table 21 Market For Mice Model: Size for Embryonic Stem Cell Injection, By Country, 2014–2021 (USD Thousand)
Table 22 Mice Model Market Size for Nuclear Transfer, By Country, 2014–2021 (USD Thousand)
Table 23 Market Size for Other Technologies, By Country, 2014–2021 (USD Thousand)
Table 24 Global Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 25 Indicative List of Recent Cancer Research Studies Using Mice Models
Table 26 Market For Mice Model: Size for Oncology Studies, By Country/Region, 2014–2021 (USD Million)
Table 27 Mice Model Market Size for Immunology and Inflammation Studies, By Country/Region, 2014–2021 (USD Million)
Table 28 Market For Mice Model: Size for Diabetes Studies, By Country/Region, 2014–2021 (USD Million)
Table 29 Mice Model Market Size for Cardiovascular Studies, By Country/Region, 2014–2021 (USD Million)
Table 30 Recent CNS Disorder-Related Research Studies Using Mice Models
Table 31 Mice Model Market Size for CNS Studies, By Country/Region, 2014–2021 (USD Million)
Table 32 Market For Mice Model: Size for Other Disease Studies, By Country/Region, 2014–2021 (USD Million)
Table 33 Global Mice Care Products Market Size, By Type, 2014–2021 (USD Million)
Table 34 Mice Cages Market Size, By Region, 2014–2021 (USD Thousand)
Table 35 Mice Feed Market Size, By Region, 2014–2021 (USD Thousand)
Table 36 Mice Bedding Market Size, By Region, 2014–2021 (USD Thousand)
Table 37 Other Mice Care Products Market Size, By Region, 2014–2021 (USD Thousand)
Table 38 Global Mice Model Market Size, By Region, 2014–2021 (USD Million)
Table 39 North America: Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 40 North America: Market Size, By Type, 2014–2021 (USD Million)
Table 41 North America: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 42 North America: Market Mice Model: Size, By Service, 2014–2021 (USD Million)
Table 43 North America: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 44 North America: Market Size, By Care Product, 2014–2021 (USD Million)
Table 45 NIH Funding for Projects Related to Animal Models
Table 46 Associations Directly Related to the Animal Model Market
Table 47 Associations Indirectly Related to the Animal Model Market
Table 48 U.S.: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 49 U.S.: Market Mice Model: Size, By Technology, 2014–2021 (USD Million)
Table 50 U.S.: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 51 U.S.: Market Size, By Application, 2014–2021 (USD Million)
Table 52 Canada: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 53 Canada: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 54 Canada: Market Size, By Service, 2014–2021 (USD Thousand)
Table 55 Canada: Market Mice Model: Size, By Application, 2014–2021 (USD Million)
Table 56 Europe: Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 57 Europe: Market Size, By Type, 2014–2021 (USD Million)
Table 58 Europe: Mice Model Market Size, By Technology, 2014–2021 (USD Million)
Table 59 Europe: Market Size, By Service, 2014–2021 (USD Million)
Table 60 Europe: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 61 Europe: Market Mice Model: Size, By Care Product, 2014–2021 (USD Thousand)
Table 62 Germany: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 63 Germany: Market Size, By Technology, 2014–2021 (USD Million)
Table 64 Germany: Mice Model Market Size, By Service, 2014–2021 (USD Million)
Table 65 Germany: Market Size, By Application, 2014–2021 (USD Million)
Table 66 U.K.: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 67 U.K.: Market Size, By Technology, 2014–2021 (USD Million)
Table 68 U.K.: Market Size, By Service, 2014–2021 (USD Million)
Table 69 U.K.: Market Mice Model: Size, By Application, 2014–2021 (USD Million)
Table 70 France: Mice Model Market Size, By Type, 2014–2021 (USD Thousand)
Table 71 France: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 72 France: Market Size, By Service, 2014–2021 (USD Thousand)
Table 73 France: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 74 European Animal Care Associations and Their Events
Table 75 Pharma 2020: Implementation
Table 76 RoE: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 77 RoE: Market Size, By Technology, 2014–2021 (USD Million)
Table 78 RoE: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 79 RoE: Market Mice Model: Size, By Application, 2014–2021 (USD Million)
Table 80 Asia-Pacific: Mice Model Market Size, By Country, 2014–2021 (USD Million)
Table 81 Asia-Pacific: Market Size, By Type, 2014–2021 (USD Million)
Table 82 Asia-Pacific: Mice Model Market Size, By Technology, 2014–2021 (USD Thousand)
Table 83 Asia-Pacific: Market Size, By Service, 2014–2021 (USD Million)
Table 84 Asia-Pacific: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 85 Asia-Pacific: Market Size, By Care Product, 2014–2021 (USD Thousand)
Table 86 China: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 87 China: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 88 China: Market For Mice Model: Size, By Service, 2014–2021 (USD Thousand)
Table 89 China: Mice Model Market Size, By Application, 2014–2021 (USD Million)
Table 90 Japan: Significant Partnerships
Table 91 Japan: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 92 Japan: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 93 Japan: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 94 Japan: Market For Mice Model: Size, By Application, 2014–2021 (USD Million)
Table 95 Study Results Regarding R&D Expenditure of 25 Pharmaceutical Companies
Table 96 India: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 97 India: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 98 India: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 99 India: Market Size, By Application, 2014–2021 (USD Million)
Table 100 RoAPAC: Player Activity, 2013 to 2015
Table 101 RoAPAC: Mice Model Market Size, By Type, 2014–2021 (USD Million)
Table 102 RoAPAC: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 103 RoAPAC: Mice Model Market Size, By Service, 2014–2021 (USD Thousand)
Table 104 RoAPAC: Market Size, By Application, 2014–2021 (USD Million)
Table 105 RoW: Mice Model Market Size, By Type, 2014–2021 (USD Thousand)
Table 106 RoW: Market Size, By Technology, 2014–2021 (USD Thousand)
Table 107 RoW: Market For Mice Model: Size, By Service, 2014–2021 (USD Thousand)
Table 108 RoW: Mice Model Market Size, By Application, 2014–2021 (USD Thousand)
Table 109 RoW: Market Size, By Care Product, 2014–2021 (USD Thousand)
Table 110 Alliances, Collaborations, Agreements, Joint Ventures, and Partnerships (2013–2016)
Table 111 Grants & Funds, 2013–2016
Table 112 Key Players Focusing on Expansions (2013–2016)
Table 113 Product Launches (2013–2016)
Table 114 Acquisitions (2013–2016)
Table 115 Licensing (2013–2016)
Table 116 Key Players Focusing on Other Strategies (2013–2016)
 
 
List of Figures (46 Figures)
 
Figure 1 Global Mice Model Market: Research Methodology Steps
Figure 2 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 3 Market Size Estimation Methodology: Bottom-Up Approach
Figure 4 Market Size Estimation Methodology: Top-Down Approach
Figure 5 Mice Model Market Forecast Design
Figure 6 Data Triangulation Methodology
Figure 7 Global Market, By Technology (2016 vs 2021)
Figure 8 Global Mice Model Market, By Type (2016 vs 2021)
Figure 9 Global Market, By Service (2016 vs 2021)
Figure 10 Global Market For Mice Model: By Application (2016 vs 2021)
Figure 11 Global Mice Care Products Market, By Type (2016 vs 2021)
Figure 12 Asia-Pacific to Register the Highest Growth During the Forecast Period
Figure 13 Growing Pharma R&D and Increasing Funding are Expected to Drive the Global Mice Model Market During the Forecast Period
Figure 14 North America to Dominate the Mice Care Products Market in 2016
Figure 15 Crispr to Account for the Largest Share of the Global Mice Model Market, By Technology
Figure 16 Asia-Pacific to Register the Highest Growth in the Global Mice Model Market From 2016 to 2021
Figure 17 Mice Model Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Clinical Studies Using Mice Models, By Indication (2013 Onwards)
Figure 19 Clinical Studies Using Mice Models, By Completion (2013 Onwards)
Figure 20 Clinical Studies Completion Estimates Per Year (2014–2022)
Figure 21 Genetically Engineered Mice to Be the Fastest-Growing Mice Model Market Segment During the Forecast Period
Figure 22 Breeding Services Accounted for the Largest Share of the Mice Model Market in 2016
Figure 23 Crispr Technology Segment to Dominate the Mice Model Technology Market in 2016
Figure 24 Oncology to Dominate the Mice Model Market in 2016
Figure 25 Cages Accounted for the Largest Share of the Mice Care Products Market in 2016
Figure 26 Asia-Pacific to Grow at the Highest CAGR in the Mice Model Market During the Forecast Period
Figure 27 North America: Mice Model Market Snapshot
Figure 28 Germany to Dominate the European Mice Model Market in 2016
Figure 29 Number of Cell Therapy Preclinical Studies Listed in the Preclinical Research Database in the U.K., 2013–2016
Figure 30 China: the Fastest-Growing Country in the Asia-Pacific Mice Model Market During the Forecast Period
Figure 31 Oncology Studies to Dominate the RoW Mice Model Market, By Application
Figure 32 Major Players Focused on Inorganic Growth Strategies (2013-2016)
Figure 33 Global Mice Model Market Share, By Key Player, 2015
Figure 34 Battle for Market Share: Alliances, Agreements, Collaborations, Joint Ventures, and Partnerships Formed the Key Growth Strategy
Figure 35 Alliances, Collaborations, Agreements, Joint Ventures, and Partnerships (2013–2016), By Company
Figure 36 Key Players Focusing on Grants & Funds (2013-2016)
Figure 37 Key Players Focusing on Expansions (2013-2016)
Figure 38 Key Players Focusing on Product Launches (2013-2016)
Figure 39 Key Players Focusing on Acquisitions (2013-2016)
Figure 40 Key Players Focusing on Licensing (2013-2016)
Figure 41 Key Players Focusing on Other Strategies (2013-2016)
Figure 42 Business Focus of the Top 3 Market Players
Figure 43 Charles River Laboratories International, Inc.: Company Snapshot (2015)
Figure 44 The Jackson Laboratory: Company Snapshot (2015)
Figure 45 Laboratory Corporation of America Holdings: Company Snapshot (2015)
Figure 46 Trans Genic, Inc.: Company Snapshot (2015)

The mice model market is expected to reach USD 1.59 Billion in 2021 from USD 1.11 Billion in 2016, growing at a CAGR of 7.5%. Ongoing innovations in mice models, personalized medicine driving the demand for humanized mice models, continuous support in the form of investments and grants, and growing pharmaceutical R&D activities are some of the factors that are expected to drive the growth of the global market in the coming years. On the other hand, factors like advancements in genetic techniques for the development of genetically modified rats have led to the increased usage of rat models, thereby restraining the market to some extent.

The market is segmented on the basis of type, technology, application, service and mice care products. By type, the market is categorized into inbred mice, genetically engineered mice, conditioned/surgically modified mice, hybrid/congenic mice, outbred mice, and spontaneous mutant mice. The inbred mice are estimated to account for the largest share of the market, by type. However, knockout mice models are expected to be the fastest-growing market segment owing to the popularity of CRISPR technology for creating gene knockouts, high investments in the development of new and innovative knockout models that also increases the application areas for these models.

On the basis of technology, the market is segmented into CRISPR, microinjection, embryonic stem cell injection, nuclear transfer, and other technologies. Other technologies include genetically modified sperm-mediated gene transfer, virus/vector mediated gene transfer, liposome-mediated DNA & electroporation of DNA, biolistics, and TALENs & ZFN. In 2016, CRISPR technology is expected to command the largest share of the market, by technology.

The mice model market is further segmented by application, which includes oncology studies, immunology & inflammation studies, diabetes studies, cardiovascular studies, central nervous system studies, and other disease studies. Other disease studies include rare diseases, renal disorders, hematopoiesis, and toxicology studies. In 2016, the oncology segment is expected to command the largest share of the market, by application.

The market, by service, has been segmented into breeding, quarantine, rederivation, cryopreservation, genetic testing, model in-licensing, and other services. Other services include surgical, line rescue, and in vivo pharmacology services. In 2016, breeding services are expected to command the largest share of the market, by services.

The market also covers the mice care products market, by type, which includes bedding, cages, feed, and other products (gnotobiotic equipment, water systems, and accessories like washing systems, logistics, water purification systems, sound absorption panels). In 2016, cages command the largest share of the global mice care products market.

Mice Model Market

The mice model market is expected to be dominated by North America, followed by Europe, Asia-Pacific, and the Rest of the World (RoW). Asia-Pacific is expected to grow at the highest rate during the forecast period.

Charles River Laboratories International, Inc. (U.S.), The Jackson Laboratory (U.S.), Taconic Biosciences, Inc. (U.S.), Envigo (U.K.), Laboratoratory Corporation of America Holdings (U.S.), JANVIER LABS France), Harbour BioMed (China), TRANS GENIC, Inc. (Japan), genOway (France), and Horizon Discovery Group plc (U.S.) are some of the key players in the global mice model market.

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports



Access reports on all high
growth Biotechnology Markets on KnowledgeStore
Request Demo